Beyond Trial Matching: Keeping Community Oncologists Connected Through Shared Care

October 18, 2026

Community oncology practices may identify a clinical trial that warrants consideration, but an important question remains: how can they help patients explore research opportunities while maintaining communication with their existing care team?

Clinical-trial matching is only one step in a broader care process. Patients may need specialist evaluations, additional assessments, and discussions about eligibility at another institution. Without clear communication and follow-up responsibilities, community oncologists may have difficulty staying informed about these steps.

Community oncology practices can help maintain patient continuity after a clinical-trial referral by clarifying follow-up responsibilities, establishing communication with the receiving institution, and discussing how relevant evaluation updates will be shared. When appropriate, the community oncologist and receiving team can also clarify plans for ongoing care after the evaluation. 1104Health’s physician-first Oncology Collaboration Network supports collaboration between community oncologists and academic specialists, extending the conversation beyond trial matching alone.

Why Trial Matching Is Only the Beginning

Identifying a potentially relevant clinical trial does not automatically establish a patient’s eligibility or determine where all subsequent care will take place. Eligibility depends on the study requirements and the patient’s clinical circumstances, while care arrangements vary by institution and trial protocol.

For community oncologists, the process also involves understanding how the patient’s evaluation will be coordinated and how relevant updates can be communicated to the existing care team.

Several questions deserve attention when a referral is being considered:

  • Who will coordinate the initial referral and confirm receipt of the relevant records?
  • How will the community oncologist communicate with the receiving specialist?
  • Who will share relevant updates about the evaluation and next steps?
  • How will the patient understand the responsibilities of each participating care team?

These questions help practices consider patient continuity alongside trial identification. They also provide a starting point for identifying workflow gaps that may need attention.

Explore the 1104Health oncology collaboration network to learn more about its approach to physician collaboration and shared care.

How Community Oncologists Can Stay Connected After a Clinical-Trial Referral

Effective clinical trial referral follow-up involves more than sending records to another institution; it also requires clear communication, defined responsibilities, and appropriate updates between participating care teams. Practices can establish processes that clarify responsibilities and support appropriate information exchange throughout the patient’s evaluation.

Establish Clear Physician Communication

Before a referral proceeds, the community practice can identify the appropriate specialist contact and clarify how relevant clinical questions will be addressed.

A defined communication process can help physicians understand their respective responsibilities and establish expectations for sharing updates. The appropriate arrangement will depend on institutional procedures, privacy requirements, and the patient’s care plan.

Clarify Follow-Up Responsibilities

Referral workflows can become difficult to manage when neither team knows who is responsible for confirming appointments, requesting missing records, or communicating the next steps.

Practices can document responsibility for these tasks and establish a process for following up on unresolved requests. Clear ownership can make it easier to identify outstanding actions without relying entirely on repeated phone calls and informal messages.

Keep Patients Informed About Their Care Arrangements

Patients may have questions about why a specialist evaluation is recommended, what the next steps involve, and how their existing oncology team will remain informed.

Physicians can discuss the proposed care arrangements and explain how communication between participating teams is expected to work. Patients should understand whom to contact with questions and what information can be shared, subject to applicable consent and privacy requirements.

Plan for Communication After the Evaluation

The receiving institution’s evaluation may lead to additional testing, further discussion, trial enrollment consideration, or other clinical recommendations. The next steps depend on the individual circumstances.

Community and academic teams can establish a process for sharing relevant evaluation updates and clarifying ongoing care responsibilities. When trial evaluation or treatment at another institution concludes, the teams can also clarify the next steps for follow-up with the community oncologist, where appropriate. This helps keep communication and care planning connected beyond the initial referral.

How Can Community Oncologists Keep Patients Connected After a Trial Referral?

Maintaining the physician relationship requires a plan for communication before, during, and after an outside evaluation. Community practices can identify the receiving specialist, clarify who will communicate relevant updates, and discuss how the patient’s ongoing care will be coordinated.

When trial-related evaluation or treatment takes place at another institution, the participating teams can clarify which aspects of care remain with the community practice and how follow-up will be arranged, where appropriate. These plans depend on the patient’s clinical needs, trial requirements, and institutional procedures.

A physician-first shared-care approach puts these communication arrangements alongside trial identification, helping the care teams consider continuity throughout the process.

Recognizing Oncology Referral Bottlenecks

Oncology referral bottlenecks can occur when documentation, scheduling, specialist review, and follow-up depend on disconnected workflows.

For example, a community practice may submit a referral but have difficulty confirming whether the receiving team has obtained the required records. After the evaluation, the treating physician may need to request additional information to understand the recommendations and determine the appropriate next steps within the patient’s care plan.

Recurring issues may include:

  • Missing or incomplete referral documentation.
  • Uncertainty about appointment status.
  • Repeated requests for records or clinical updates.
  • Unclear responsibility for communicating relevant information.
  • Delays in obtaining information needed for continued care coordination.

These issues do not necessarily mean a referral has failed. They may reflect differences in institutional processes or documentation requirements.

Practices can review the time between referral submission and confirmation, the frequency of outstanding records requests, and whether follow-up is documented. Reviewing these measures over time can help identify recurring coordination challenges and areas where process changes may be appropriate.

Signs of Poor Care Coordination Across Oncology Settings

Signs of poor care coordination may become visible when patients receive care from multiple institutions. Records may be difficult to access, communication responsibilities may be unclear, or physicians may have limited visibility into relevant steps taking place elsewhere.

Patients may need to repeat information, while administrative staff may spend additional time contacting offices to confirm the status of a referral or obtain updates.

These patterns can contribute to oncology practice inefficiencies when routine communication depends on repeated manual follow-up.

Practices can begin by reviewing how information moves between teams. Consider whether the referring physician knows whom to contact, whether relevant records are available for review, and whether follow-up responsibilities are documented.

The goal is not to require identical workflows across every institution. It is to identify practical arrangements that support communication while respecting each team’s clinical responsibilities and existing procedures.

Why Oncology Network Infrastructure Matters

Oncology network infrastructure can provide a framework for professional connections and communication between community practices and academic specialists.

For a community oncologist, access to specialist expertise is only one consideration. The practice may also need an appropriate way to discuss a complex case, share relevant information, and coordinate next steps with participating physicians.

A connected professional network can support these activities by helping establish relationships between physicians across care settings. Depending on the services available, collaboration may include case discussions, specialist perspectives, and communication around relevant clinical questions.

A shared-care approach recognizes that a patient may receive services from more than one institution while participating physicians maintain their respective responsibilities. The specific arrangement depends on the patient’s needs, the institutions involved, and applicable clinical and operational requirements.

This is an important distinction: an oncology collaboration network is not simply a way to locate a specialist or identify a trial. It can also provide a framework for ongoing professional communication across participating settings.

How 1104Health Supports Case Prep and Physician Collaboration

1104Health’s physician-first Oncology Collaboration Network connects community oncologists with academic specialists. Its approach includes Case Prep and Curbside Consults, physician communication, and care coordination across participating care settings.

Rather than focusing on trial matching alone, this approach also emphasizes physician collaboration and communication around the patient’s care. The specific responsibilities and follow-up arrangements depend on the participating clinicians, institutions, and individual care plan.

Case Prep supports the organization of oncology case information for physician review. Depending on the workflow and available information, it can include consideration of relevant research opportunities as one component of a broader case review.

Curbside Consults provide a format for physician-to-physician discussion when additional specialist input may be useful.

Physician collaboration provides a framework for professional connections between community and academic oncologists, supporting discussions and communication across participating settings.

These capabilities are relevant when practices evaluate how they prepare cases and coordinate with other physicians. The specific services and workflows available should be assessed against the needs of the practice and its participating clinicians.

For clinical-trial referrals, this broader perspective keeps the focus on physician communication and coordinated care rather than trial matching alone.

Modernizing Oncology Practice Workflows

Modernizing oncology practice workflows does not necessarily require replacing every existing system. Practices can begin by identifying where information exchange, follow-up, or communication repeatedly becomes difficult.

A focused review can cover three areas.

First, evaluate referral visibility. Determine whether staff can establish the status of a referral and identify outstanding actions without repeatedly contacting multiple offices.

Second, review information handoffs. Assess whether relevant clinical information reaches the appropriate physicians through established communication channels and whether follow-up responsibilities are clear.

Third, examine opportunities for physician collaboration. Consider whether clinicians have practical ways to identify specialist expertise, prepare cases for discussion, and communicate about questions that require additional input.

Practices can track selected measures, such as unresolved records requests, documented referral follow-up, and recurring communication issues. These measures can help leadership identify where targeted improvements may be appropriate.

The most suitable changes will depend on existing systems, staffing, institutional requirements, and the resources available to support new processes.

Keeping Patient Continuity at the Center of Shared Care

Clinical-trial matching can help identify research opportunities for further consideration, but it does not resolve every coordination need that follows a referral.

Community oncology practices also need to consider communication with receiving specialists, appropriate information exchange, follow-up responsibilities, and the patient’s understanding of their care arrangements.

A shared-care framework can help participating physicians clarify these responsibilities and maintain professional communication across care settings. It does not guarantee that every patient will remain with the same physician for every aspect of care, because arrangements depend on clinical needs, trial requirements, and institutional policies.

1104Health supports this broader approach through its physician-first Oncology Collaboration Network, with an emphasis on Case Prep, Curbside Consults, physician communication, and care coordination between community and academic oncology settings.

FAQs

1. How can community oncology practices match patients to trials without losing the physician relationship?

Practices can consider relevant research opportunities as part of Case Prep while establishing communication and follow-up processes with participating specialists. Care arrangements depend on the patient’s needs, trial requirements, and institutional procedures.

2. How can community oncologists stay informed after referring a patient to an academic center?

The referring practice can establish an appropriate contact process, clarify how relevant updates will be communicated, and document follow-up responsibilities. Information sharing must follow applicable consent, privacy, and institutional requirements.

3. Does a clinical-trial referral mean a patient must transfer all oncology care?

Not necessarily. Care arrangements vary according to the clinical situation, trial protocol, and institutions involved. The participating teams should clarify which services will be provided at each setting and how responsibilities will be coordinated.

4. What causes oncology referral bottlenecks?

Potential causes include incomplete documentation, unclear ownership of follow-up tasks, scheduling challenges, disconnected records, and limited communication between referring and receiving teams. Reviewing these steps can help practices identify recurring problems.

5. How can Case Prep support clinical-trial discussions?

Case Prep can help organize relevant case information for physician review. Depending on the available information and workflow, it may support consideration of relevant research opportunities and questions for specialist discussion. Trial eligibility requires assessment against the applicable study requirements.

6. What role can an oncology collaboration network play in shared care?

An oncology collaboration network can provide a framework for professional connections, case discussions, and communication between community oncologists and academic specialists. Its practical role depends on the services available and the arrangements established by participating physicians.

7. What should practices review first when improving care coordination?

Start with referral documentation, confirmation of receipt, follow-up responsibilities, and communication after specialist evaluation. Tracking recurring issues can help the practice identify which workflow changes warrant further review.

8. How can community oncologists stay involved when a patient receives trial-related care at another institution?

Community oncologists and the receiving team can clarify communication responsibilities, agree on how relevant updates will be shared, and discuss follow-up arrangements when appropriate. The care plan depends on the patient’s clinical needs, trial requirements, and the institutions involved.

SHARE

RELATED POSTS